Helmut Denk

Active 1971–2021

77
Papers
19,635
Citations
72
h-index
76
i10-index

Citations

Citations per year for Helmut Denk1972: 3 citations1973: 2 citations1974: 3 citations1975: 2 citations1976: 3 citations1977: 3 citations1978: 5 citations1979: 8 citations1980: 11 citations1981: 25 citations1982: 67 citations1983: 92 citations1984: 63 citations1985: 77 citations1986: 77 citations1987: 55 citations1988: 47 citations1989: 44 citations1990: 25 citations1991: 27 citations1992: 27 citations1993: 26 citations1994: 20 citations1995: 19 citations1996: 24 citations1997: 24 citations1998: 49 citations1999: 47 citations2000: 56 citations2001: 65 citations2002: 120 citations2003: 108 citations2004: 132 citations2005: 166 citations2006: 200 citations2007: 167 citations2008: 216 citations2009: 172 citations2010: 178 citations2011: 183 citations2012: 177 citations2013: 182 citations2014: 159 citations2015: 156 citations2016: 126 citations2017: 132 citations2018: 112 citations2019: 376 citations2020: 423 citations2021: 486 citations2022: 389 citations2023: 291 citations2024: 427 citations2025: 274 citations2026: 50 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,844 citing papers, 22.4% of this breakdownChina: 785 citing papers, 9.5% of this breakdownGermany: 697 citing papers, 8.5% of this breakdownUnited Kingdom: 535 citing papers, 6.5% of this breakdownItaly: 457 citing papers, 5.6% of this breakdownAustria: 328 citing papers, 4% of this breakdownJapan: 312 citing papers, 3.8% of this breakdownFrance: 246 citing papers, 3% of this breakdownCanada: 212 citing papers, 2.6% of this breakdownNetherlands: 199 citing papers, 2.4% of this breakdownSpain: 190 citing papers, 2.3% of this breakdownAustralia: 175 citing papers, 2.1% of this breakdown
0%22.4%Other 27.3%

Fields

  • Medicine59.4%
  • Biochemistry, Genetics and Molecular Biology23.5%
  • Computer Science8.4%
  • Pharmacology, Toxicology and Pharmaceutics1.4%
  • Immunology and Microbiology1.3%
  • Neuroscience1.2%
  • Other4.8%

Topics

  • Liver Disease Diagnosis and Treatment8.1%
  • Drug Transport and Resistance Mechanisms3.6%
  • Liver physiology and pathology3.5%
  • Liver Diseases and Immunity3.2%
  • Hepatitis C virus research3.1%
  • Liver Disease and Transplantation2.5%
  • Other76%

Coauthors

All papers

Open in search
  1. Causability and explainability of artificial intelligence in medicine

    Authors: , , , , - Wiley Interdisciplinary Reviews Data Mining and Knowledge Discovery, WIREs Data Mining Knowl. Discov. 2019 cited by 1,740

  2. Histological grading and staging of chronic hepatitis

    Authors: , , , , , , , , , , , , , , , - Journal of Hepatology 1995 cited by 5,054

  3. From the origin of NASH to the future of metabolic fatty liver disease

    Authors: , , , - Gut 2021 cited by 92

  4. p62 Is a Common Component of Cytoplasmic Inclusions in Protein Aggregation Diseases

    Authors: , , , , , , , , , - American Journal Of Pathology 2002 cited by 617

  5. A New Xenobiotic-Induced Mouse Model of Sclerosing Cholangitis and Biliary Fibrosis

    Authors: , , , , , , , , , , - American Journal Of Pathology 2007 cited by 378

  6. CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice†

    Authors: , , , , , , , , - Hepatology 2005 cited by 346

  7. Characterization of HULC, a Novel Gene With Striking Up-Regulation in Hepatocellular Carcinoma, as Noncoding RNA

    Authors: , , , , , , , , , , - Gastroenterology 2006 cited by 777

  8. Liver Phenotypes of European Adults Heterozygous or Homozygous for Pi∗Z Variant of AAT (Pi∗MZ vs Pi∗ZZ genotype) and Noncarriers

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alexander Teumer, Jef Verbeek, Frederik Nevens, Olivier Govaere, Marcin Krawczyk, Tania Roskams, Johannes Haybaeck, Georg Lurje, Joanna Chorostowska‐Wynimko, Joan Genescà, Thomas Reiberger, Frank Lammert, Aleksander Krag, Jacob George, Quentin M. Anstee, Michael Trauner, Christian Datz, Nadine T. Gaisa, Helmut Denk, Christian Trautwein, Elmar Aigner, Pavel Strnad - Gastroenterology 2020 cited by 98

  9. Bile acids trigger cholemic nephropathy in common bile-duct-ligated mice

    Authors: , , , , , , , , , , , , , , , , , - Hepatology 2013 cited by 177

  10. Farnesoid X Receptor Critically Determines the Fibrotic Response in Mice but Is Expressed to a Low Extent in Human Hepatic Stellate Cells and Periductal Myofibroblasts

    Authors: , , , , , , , , , , , , , , , , , , , - American Journal Of Pathology 2009 cited by 169

  11. 24-norUrsodeoxycholic Acid Is Superior to Ursodeoxycholic Acid in the Treatment of Sclerosing Cholangitis in Mdr2 (Abcb4) Knockout Mice

    Authors: , , , , , , , , , , , , , - Gastroenterology 2006 cited by 299

  12. Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice

    Authors: , , , , , , , , , , , , - Gastroenterology 2004 cited by 463

  13. Lithocholic Acid Feeding Induces Segmental Bile Duct Obstruction and Destructive Cholangitis in Mice

    Authors: , , , , , , , , , - American Journal Of Pathology 2006 cited by 183

  14. Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice

    Authors: , , , , , , , , , , , , - Gastroenterology 2003 cited by 261

  15. Development and prognostic relevance of a histologic grading and staging system for alcohol-related liver disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2021 cited by 67

  16. Ursodeoxycholic acid aggravates bile infarcts in bile duct–ligated and Mdr2 knockout mice via disruption of cholangioles

    Authors: , , , , , , , , , , - Gastroenterology 2002 cited by 308

  17. Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis

    Authors: , , , , , , , - Journal of Hepatology 2003 cited by 272

  18. Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease

    Authors: , , , , , , - Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin 2011 cited by 137

  19. Expression of bile acid synthesis and detoxification enzymes and the alternative bile acid efflux pump MRP4 in patients with primary biliary cirrhosis

    Authors: , , , , , , , - Liver International 2007 cited by 127

  20. Histone deacetylase inhibitor vorinostat suppresses the growth of uterine sarcomas in vitro and in vivo

    Authors: , , , , , , - Molecular Cancer 2010 cited by 92

  21. Sequestosome 1/p62-related pathways as therapeutic targets in hepatocellular carcinoma

    Authors: , , , - Expert Opinion on Therapeutic Targets 2019 cited by 33

  22. Role of nuclear bile acid receptor, FXR, in adaptive ABC transporter regulation by cholic and ursodeoxycholic acid in mouse liver, kidney and intestine

    Authors: , , , , , , , , , , - Journal of Hepatology 2003 cited by 192

  23. Coordinated induction of bile acid detoxification and alternative elimination in mice: role of FXR-regulated organic solute transporter-α/β in the adaptive response to bile acids

    Authors: , , , , , , , , , , - American Journal of Physiology-Gastrointestinal and Liver Physiology 2005 cited by 175

  24. Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2 −/− mice†‡§

    Authors: , , , , , , , , , , , , , , , - Hepatology 2009 cited by 153